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Substituted anilines are coupled with furoic acid and furfural at the position-S to get 5-(p-
chlorophenyl)furan-2-carboxylic acid and 4-[2'-(5' -formyl) furyl]benzoic acid which on further
coupling with amino acid esters, di-, tetra- and hexapeptides yield 5-(p-chlorophenyl)furan-2-
carboxylamino acid esters and peptides and 4-[2'-(5'-formyl) furyl]benzoyl amino acid esters and
peptides. The structures of these compounds have been confirmed by elemental and spectral analysis.
The biological activity of these compounds are reported.
Prompted by the varied biological properties of
peptides', substituted phenyl furan derivatives',
bromo furoyl amino acids', nitro furan acryloyl
amino acid methyl esters', 2-furylacryloylamino
acids and dipeptide derivatives", substituted furan
amino acid derivatives' and furan peptides", it was
contemplated to synthesise first aryl substituted
furoic acid and furyl substituted benzoic acid and
then condense them with different amino acid
esters and peptides using DCC as the coupling
agent.
Diazotised solution of p-aminobenzoic acid with
furfural gives 4- [2'- (5'-formyl)furyl]benzoic acid
1 (cf. Scheme I). p-chloroaniline was substituted to
furoic acid at position-5 after diazotisation to give
5-(p-chlorophenyl)furan-2-carboxylic acid 2 (cf.
Scheme H),which was confirmed by undepressed
mixed melting point with authentic samples".
For the amino group protection of L-proline, L-
phenylalanine and L-valine, di-tert-butyl
pyrocarbonate (Boc-O-Boc) was used and
carboxylic group of L-proline, t.-valine and L-




OMe, N-13oc-Phe-Tyr-OMe were prepared from
the corresponding amino acid methyl esters and
'Boo-amino acids using DCC as a coupling agent
and NMM as a base in dichloromethane. The
reaction mixtures were stirred for 24 hr at room
temperature.
The N-13oc group was removed using
CF3COOR/CRCl3 and the methyl ester group was
removed using LiOR at room temperature.
The tetrapeptide N-13oc-Val-Val-Pro-Val-OMe
was prepared from dipeptides N-13oc-Val-Val-
OMe and N-13oc-Pro-Val-OMe using DCC and
NMM after proper deprotection. Similarly,
tetrapeptide N-13oc-Val-Pro-Phe-Tyr-OMe was
prepared from dipeptides N-13oc-Val-Pro-OMe
and N-13oc-Phe-Tyr-OMe after proper
deprotection.
The hexapeptide N-13oc- Pro- Pro- Val- Pro- Phe-
Tyr-OMe was prepared from N-13oc-Pro-Pro-OMe
and N-13oc-Val-Pro-Phe-Tyr-OMe after proper
deprotection of the amino and carboxyl groups by
using DCC and NMM as the coupling reagents.
4-[2'-(5'-Formyl)furyl]benzoic acid and valine
methyl ester hydrochloride were coupled using
DCC and NMM. The procedure was the same as
that used for the preparation of dipeptides. The
resulting compound was then subjected to
deprotection of the methyl ester group using LiOR
to obtain 4-[2'-(5'-formyl)furyl]benzoyl valine 3a
(cf. Scheme III5.
The N-13oc group of N-13oc-Pro-Leu-OMe and
N-13oc-Pro-Pro-OMe was removed using
CF3COOHI CRCI3. The free carbonyl end of 5'-
[formyl)furyl]benzoic acid arid the free end of
dipeptides H-Pro-Leu-OMe and R-Pro-Pro-OMe
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H~C-{ }NHz. _o~> HOZC-<, }'rf_N}Cf>-_b_.:;.> H~C-OVCHO
1
Reagents.:
a = NaNOz./HCl b =
~CHO/CuClz.
Scheme I
Cl -<' }NHz. _-=--a~> 0-<, }W.N}Cr--_b_~> Cl-oQ-CDzH
2
> -0-0-:1II \\OHC I \ CO-X-OH
o - 3
l-Vol, l-Pro-l-leu, L-Pro-L-Pro, L-Vol-L-Vol-L- Pro-L-Vol
Reagents:
b =
OHC-O-o-COzH + H-x - OMe
b
Where, X=
Ren q ent s :
Scheme II
a > OHCVQ-CO-X-OMe
a= CHz.Clz., DCC, NMM, 2l,.hrs, RT
b = THF: HzO{1:1), LiOH, 1hr, RT
Scheme ill
were coupled to obtain 4-[2'-(5' -fonnyl)furyl]-
benzoyl-prolyl- leucine methyl ester 3b and 4-[2'-
(5' -formyl) ]benzoyl- furyl-prolyl-proline methyl
ester. The methyl group of the latter compound
was deprotected using LiOR (cf. Scheme III)
to obtain 4-[2' -(5' -fonnyl)furyl]benzoyl-prolyl-
proline 3c.
The 'Boc-group of N-13oc-Val-Val-Pro-Val-
OMe was removed using CF3COOHlCRCl3 and
was coupled with 4-[2'-(5'-fonnyl)furyl]benzoic
acid and 5-(p-chlorophenyl)furan-2-carboxylic
acid respectively. The resulting compounds were
subjected to methyl ester group deprotection to
obtain 4-[2'-(5' -formyljfuryl-benzoyl-valyl-valyl-
prolyl-vatine 3d and 5-(p-chlorophenyl)furan-2-
carboxyl-valyl-valyl- prolyl- valine 4a( cf. Scheme
IV).
Similarly 130c deprotected hexapeptide N-13oc-
Pro-Pro-Val-Pro-Phe-Try-OMe was coupled with
5-(p-chlorophenyl)furan-2-carboxylic acid. The
ester group of the resulting compound was
removed using LiOR to obtain 5-(p-
chorophenyl)furan-2-carboxyl-prolyl- prolyl-valyl-
prolyl-phenylalanyl-tryptophan 4b (cf. Scheme
IV).
All the newly synthesized compounds were
confirmed by elemental analyses and spectral data.
Yieldwise, DCC is found to be the good coupling
agent.
Biological activity
The antifungal and antibacterial activity of all
newly synthesized compounds were tested against
Bacillus subtillis, Staphylococcus aureus,
Escherichia coli, Pseudomonas aerugirosa and
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Reagent!> :
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Scheme IV
Table I-Antibacterial and antifungal activity of compounds 1,3a-d and 4a,b
Zone of inhibition (in mm) at IOJ..LgJconcentration














Candida albicans at 10J.1g1mLin the neutral agar
media following the disc diffusion method.
Solvent control was also run to know the activity
of blank solvent. The results are recorded in Table
I. It was observed that the antifungal and
antibacterial activities of furan derivatives were
changed after coupling with amino acid esters and
peptides.
Experimental Section
All the melting points were taken in open
capillaries and are uncorrected. IR spectra were
recorded on a Perkin-Elmer 137 instrument (Aroax
in cm') and IH NMR in continuous wave mode on
an EM-390 (90 MHz) spectrometer (chemical
shifts in 8,ppm) using CDCl3 as a solvent and TMS
as an internal standard. Purity of all compounds
were checked by TLC on silica gel G plates.
Preparation of dlpeptldes"
Amino acid ester hydrochloride (10m moles)









N-methyl morpholine (35 m moles) was added at
O°C. The reaction mixture was stirred for 15
minutes. Boc-amino acid (10 m moles) in CH2Cl2
(15 mL) and DCC (10 m moles) were added with
stirring. After 24 hr, the reaction mixture was
filtered, concentrated under reduced pressure and
diluted with ethyl acetate. The organic layer was
washed with HCI (10%), NaHC03 (10%) and
saturated NaCI solutions. The organic layer was
dried over anhydrous Na2S04, filtered, and
evaporated in vacuum. It was purified by
recrystallization from ethyl acetate / n-hexane.
Nstert- Butyloxycarbonyl-prolyl-proline meth-
yl ester 1': Dense liquid, yield 60%, IR(CHCI3):
3415(br.s), 3250(br.s), 3910(s), 2960(s), 2920(s),
2840(m), 1730(m), 1695 (s), 1645(br. s), 1500(br.
s), 1380(m), 1360(s), 1160(s), 1085(m), 1010(s)
cm', IH NMR (CDCI3, 90 MHz): 8 4.5 (2H, m),
3.72(3H, s), 3.5 (4H, m), 2.3-1.9 (8H, m), 1.6-1.5
(9H, s).
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N-tert-Butyloxycarbonyl-prolyl-Ieucine meth-
yl ester 2': Pale white crystals, m.p. 93°C, yield
66%, IR(CHCI3): 3250(br.s), 2950(s), 1710(s),
1700(s), 1620(s), 1510(m), 1420(m), 1380(s), 1360
(s), 1160 (s), 1020 (s), 1000(m) cm', IH ?\TMR
(CDCI3, 90 MHz): 8 4.2 (IH, 8, J=6.0 Hz), 3.7
(3H,s), 2.0-1.9 (2H,m), 1.65 (2H, t, J=6.5 Hz), 1.45
(9H,s), 1.35 (IH,m), 1.3-1.1 (6H,m), 1.0-0.8 (6H,
d, J=6.5 Hz).
N-tert-Butyloxycarbonyl-prolyl-valine methyl
ester 3': White crystals, m.p. 40°C, yield 60%,
IR(CHCI3): 3540(br.s), 3310(br.s), 2960(s),
2920(m), 2880(s), 1735(s), 1670(s), 1520(br. s),
1390(s), 1245(m), 1155(s), 1080(s), 1020(s),
770(s) cm";! IH NMR (CDCI3 , 90 MHz): 8 4.3
(lH, m), 3.75 (3H, s), 3.5 (lH, m), 3.4 (lH,m), 2.4-
1.7 (6H,m), 1.5 (9H, s), 1.5-1.3 (lH, m), 0.9 (6H,
d, J=6.0 Hz).
N-tert-Butyloxycarbonyl-phenylalanyl-trypto-
phan methyl ester 4':White crystals, m.p. 144°C,
yield 62%, IR(CHCI3): 3500(br.s), 3400(s),
3300(br.s), 2900(s), 1750(s), 1680(m), 1610(s),
151O(m), 1360 (s), 1300(s), 1220(s), 1160(m),
1010(s), 720(s), 700(s) ern"; IH NMR (CDCI3, 90
MHz): 8 7.25-7.0 (IOH, m), 6.85 (lH, br. s),
6.4(lH, br.s), 4.85(IH,m), 4.2(IH,m), 3.6 (3H, s),
3.2(2H, d, J=6.0 Hz), 3.0(2H, d, J=6.0 Hz),
1.4(9H,s).
N-tert-Butyloxycarbonyl-valyl-valine met ••y.
ester 5': White crystals, m.p. 140°C, yield 63%,
IR(CHCI3): 3520(br.s), 3300(br.s), 2960(s),
2890(s), 1740(s), 1680(s), 1630(s), 1540(s),
1520(s), 1450(s), 1380(s), 1310(s), 1240(s),
1120(s), 1100(s), 1020(s)cm-1;', IH NMR (CDCI3,
90 MHz): 8 6.5(IH,br.s), 4.6-4.4 (lH, m), 4.2-4.0
(IH, m), 3.7(3H,s), 2.7 (IH, br. s), 1.4 (9H, s), 1.4-
1.0 (2H, m), 0.95(12H, d, J=7.5 Hz).
Preparation of tetrapeptides
N-13oc-Peptide acid (10 m moles), peptide methyl
ester (10 m moles) were dissolved in CHCl3 or
THF. To this solution NMM (35 m moles) was
added at O°c. The reaction mixture was stirred for
15 minutes. DCC (10 m moles) was then added
and stirred for 24 hr. Further work up was done as
described for the preparation of dipeptides.
N-tert-Butyloxycarbonyl-valyl- prolyl-pbenyl-
alanyl-tryptophan methyl ester 6': Dense liquid,
yield 61%, IR (CHCI3 ): 3300(br.s), 3020(s),
2950(br.s),2900(s), 1730(s), 1640(m), 1510(br.s),
1430(s), 1350(s), 1240(s), 1160(s), 1090(s),
1030(s), 1000(s), 740(s) cm', IH NMR (CDCI3, 90
MHz): 8 7.4-6.9 (10H, m), 6.85 (lH, br. s), 6.6
(IH, br. s), 6.5 (IH, br. s), 4.9 (lH, m), 4.7 (IH,
m), 4.3 (lH, m), 3.9 (lH, m), 3.65 (3H, s), 3.2 (2H,
d, J=6.0 Hz), 3.0(2H, d, J=6.0 Hz), 2.2-1.6 (6H,
m), 1.45 (9H, s), 1.35-1.2 (lH, m), 0.9 (6H, d,
J=6.0 Hz), l3C NMR (CDCI3 100.4 MHz): 8
218(s), 171.6(s), 171.5(s), 170.0(s), 150.8(s),
136.1(s), 136.0(s), 128.6(s), 128.5(s), 127.3(s),
126.9(d), 123.3(d), 122.0(d), 119.5(d), 118.3(d),
114.4(d), 111.3(d), 109.3(d), 79.6(d), 60.0(d),
52.8(d), 52.3(d), 49.3(d), 37.6(d), 33.9(t), 31.3(t),
30.4(t), 28.3(t), 27.5(t), 25.6(q), 24.9(q), 19.5(q),
19.0(q), 17.3(q), 16.9(q).
N-tert-Butyloxycarbonyl-valyl-valyl-prolyl-
valine methyl ester 7': Dense liquid, yield 60%,
IR (CHCI3 ): 3520(br.s), 3400(br.s), 3310(br.s),
2990(s), 2950(s), 2920(s), 2840(s), 1730(s),
1695(s), 1650(s), 1610(s), 1570(s), 1400(s),
1370(s), 1150(s), 1020(s), 81O(s) em:', IH NMR
(CDCI3 ,90 MHz): 8 7.15(lH, br.s), 6.8 (2H, br. s),
4.7-4.4 (3H, m), 4.2-4.0 (lH, m), 3.7 (3H, s), 3.6-
3.3(2H,m), 2.35-1.8 (4H, m), 1.45 (9H, s), 1.35-1.1
(3H, m), 0.95 (18H, d, J= 6.0 Hz).
Preparation of aryl substituted furoic acid
and aryl substituted furfurals/: A mixture of
substituted aniline (100 m moles), dil. HCI (15%,
60 mL) and water (90 mL) was heated to get a
clear solution. The solution was cooled to O°C and
diazotised with NaN02 solution (30%, 24 mL).
The diazonium salt solution was filtered and to the
filtrate, water (50 mL) and furoic acid (100 m
moles) / freshly distilled furfural (l00 m moles)
and aqueous cupric chloride (2.5 g in 10 mL of"
water) were added with stirring. The stirring was
continued for 4 hr and kept overnight. The
separated solid was collected by filtration and
washed with cold ethanol. The crude compound
was recrystallized from a mixture of ethanollDMF
to obtain pure aryl substituted furoic acid /aryl
substituted furfural.
4-[2' -(5' -Formyl)furyIJ benzoic acid 1: Orange
crystalline solid, m.p. 282°C, yield 85% (Found:
C, 66.5; H, 3.7. C12HgO. requires C, 66.7; H,
3.7%); IR(CHC13 ): 3706(s), 2820(s), 1676(s),
1660(s), 1580(s), 1510(s), 1450(s), 1400(s),
1200(s), 1050(s), 1000(s) cm', IH NMR (CDCI3 ,
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90 MHz): 8 9.7 (lH, s), 8.3 (2H, d, J= 7.5 Hz),
7.95 (2H, d, J=7.5 Hz), 7.35 (lH, d, J=5.5 Hz), 7.0
(lH, d, J=5.5 Hz),
5-(4' -Chlorophenyl) furan-2-carboxylic acid
2: White solid, m.p.197°C, yield 62%, IR (CHC13):
2855(s), 1680(s), 1662(s), 1580(s), 1476(s),
1416(s), 1260(s), 1094(s), 968(s), 831(s), 792(s)
crn', H NMR (CDC13, 90 MHz): 8 9.65(lH,s),
7.75(2H,d, J=7.5 Hz), 7.4(2H,d, J=9.0 Hz),
7.3(lH,d, J=5.5 Hz), 6.8(lH,d, J=5.5 Hz).
N-tert- Bu tyloxycarbo nyl-p rolyl-prolyl- valyl-
prolyl-phenylalanyl-tryptophan methyl ester 8':
Dense liquid, yield 50%, IR(CHC13 ): 3460(br.s),
3380(br.s), 3190(br.s), 2950(s), 2900(s), 1730(s),
1650(m), 1500(m), 1440(s), 1385(s), 1355(s),
1315(s), 1265(s), 1235(s), 1155(s), 1110(m),
1080(m), 920(m), 880(m), 855(m), 760(br.s) cm',
IH NMR (CDC13 , 90 MHz): 8 7.4-6.9 (lOH, m),
6.8-6.2 (4H, m), 4.9-4.0(6H,m), 3.6-3.4 (4H, m),
3.2 (2H, d, J=6.5 Hz), 3.0 (2H, d, J=7.0 Hz), 2.2-
1.5 (l8H, m), 1.4 (9H, s), 1.3-1.0 (lH, m),
0.9(6H,d, J=7.5 Hz), FABMS: mJz 856(M+l, 3%),
831(5), 781(l0), 684 (35),562(80),306 (62),
219( 58), 201 (68), 120( 100), 70(82).
4-[2' -(5' -formyl) furyl] benzoyl-valine 3a:
Semisolid, yield 80%, (Found: C, 64.6; H, 5.4; N,
0.3. C17H1705Nrequires C, 64.8; H, 5.5; N, 0~3%),
IR(CHC13): 3100(br.s), 2900(s), 2820(s), 1720 (br.
s), 1660(br.s), 1570(s), 1360(s), 800(s) em", IH
NMR (CDC13, 90 MHz): 8 9.7 (lH, s), 7.9 (2H, d,
J=7.5 Hz), 7.6 (2H, d, J=7.5 Hz), 7.35(IH, d, J=4.0
Hz), 6.9 (lH, d; J=4.0Hz), 6.3 (IH, br. s), 4.2 (lH,
m), 1.5-1.3 (IH, m), 0.96 (6H, d, J=6.5 Hz).
4-[2' -(5' -formyl) furyl]benzoyl-prolyl-Ieucine
methyl ester 3b: Semisolid, yield 78%, (Found: C,
65.3; H, 6.3; N, 6.3. C24H2s06N2requires C, 65.5;
H, 6.4; N, 6.4%), IR (CHC13 ): 3360 (br.s),
3000(s), 2960(s), 1760(s), 1720(s), 1680(s),
l560(s), 1480(s), l400(s), l280(s), 1080(s) crn', IH
NMR (CDC13, 90 MHz): 8 9.7 (IH, s), 7.9 (2H, d,
J= 7.5 Hz), 7.6 (2H, d, J=7.5 Hz), 7.35 (IH, d,
J=4.0Hz), 6.9 (lH, d, J=4.0 Hz), 6.4 (lH, br. s),
4.5 (lH, m), 4.25 (lH, m), 3.7 (3H, s), 3.5-3.1(2H,
br. m), 2.32-1.5(6H, m), 1.3-1.1 (IH, m), 0.95 (6H,
d, J=6.0Hz).
4-[2' -(5' -Formyl)furyl] benzoyl- prolyl-proline
3c: Semisolid, yield 76%' (Found: C, 69.9; H, 5.3;
N, 7.0.; C22H2206N2requires C, 69.0; H, 5.4; N,
7.1%), IR(CHC13): 3080(s), 2890(s), 2800(s),
1670(s), 1650(s), 1580(s), 1500(s), 1450(s),
1350(s), 1320(s), 1220(s), 830(s) em", IH NMR
(CDCI3, 90 MHz): 8 9.7(IH,s) 7.9 (2H, d, J=7.5
Hz), 7.6 (2H, d, J=7.5 Hz), 7.35 (IH, d, J=4.0 Hz),
6.9 (lH, d, J=4.0 Hz), 4.2 (2H, m), 3.6-3.1 (4H,
m), 2.2-1.6 (8H, m).
4-[2' -(5' -Formyl)furyl] benzoyl- valyl-valyl-
prolyl-valine 3d: Semisolid, yield 82%, (Found:
C, 62.1; H, 6.7; N, 9.3. C31H420sN4 requires C,
62.2; H, 7.0; N, 9.4%), IR (CHC13): 3360(br.s),
3000(s), 2880(s), 1720(s), 1700(br.s), 1680(s),
1580(s), 1560(s), 1480(s), 1400(s), 1360(s),
1240(s), 780(s) cm', IH NMR(CDC13, 90 MHz): 8
9.7 (lH, s), 7.9 (2H, d, J=7.5 Hz), 7.6 (2H, d,
J=7.5 Hz), 7.35 (lH, d, J=4.0 Hz), 6.9 (IH, d,
J=4.0 Hz), 6.4-6.2 (3H, br. s), 4.3-3.9 (4H, m), 3.6-
3.2 (2H, m), 2.1-1.6 (4H, m), 1.3-1.1 (3H, m), 0.95
(18H, d, J=6.0 Hz).
5 - (4' -Chlorophenyl)furan-2-carboxyl-valyl-
valyl-prolyl-valine 4a: Semisolid, yield 82%,
(Found: C,60.2; H, 6.7; N,9.0. C31H4107N4Cl
requirers C, 60.3; H, 6.6; N, 9.1 %), IR (CHC13):
3360(br.s), 3000(s), 2880(s), 1720(s), 1700(s),
1680(s), 1580(s), 1560(s), 1480(s), 1400(s),
1360(s), 1240(s), 780(s) cm', IH NMR(CDC13, 90
MHz): 8 8.3 (2H,d, J=7.5 Hz), 7.7 (2H, d, J=7.5
Hz), 7.2(lH, d, J=5.0 Hz), 7.0(lH, d, J=5.0 Hz),
6.4-6.2(3H, br.s), 4.3-3.9(4H,m), 3.6-3.2(2H, m),
2.1-1.6( 4H,m), 1.3-1.1 (3H,m), 0.95(18H,d,J=6.0
Hz).
5 - (4' -Chlorophenyl)furan-2-carboxyl-prolyl-
prolyl-valyl-prolyl-phenylalanyl-tryptophan 4b:
Semisolid, yield 78%, (Found: C, 64.4; H, 5.9; N,
10.2. C51H1709N7Clrequires C, 64.6; H, 6.0; N,
10.4%), IR (CHC13): 3360(br.s), 3300(br.s),
3120(br.s), 2900(s), 2850(s), 1750(br.s),
1650(br.s), 1620(s), 1560(s), 1450(s), 1360(s),
1310(s), 1240(s), 1100(s), 880(s) cm', IH NMR
(CDC13, 90 MHz): 8 8.3(2H, d, J=7.5 Hz), 8.1-
7.9(5H, m), 7.7 (2H, d, J=7.5 Hz), 7.6-7.4 (5H, m),
7.2 (IH, d, J=5.0 Hz), 7.0 (IH, d, J=5.0Hz), 6.9
(2H, br. s), 6.1 (2H, br. s), 4.6 (3H, m), 4.0 (3H,
m), 3.4-3.2 (4H, m), 3.2-2.9 (6H, m), 2.2-1.6 (12H,
m), 1.4-1.2 (lH, m), 0.95 (6H, d, J=6.0 Hz).
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